LobbyingVivex Biologics lobbying by quarter
Vivex Biologics's latest lobbying report covers Q2 2026, at $170K. The four quarters Q4 2025–Q3 2026 total $510K. Its first report covers Q1 2024; the issues it reports most are Health Issues and Medicare/Medicaid.
Vivex Biologics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $510K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2024 | $20K | 1 |
| Q2 2024 | $50K | 1 |
| Q3 2024 | $50K | 1 |
| Q4 2024 | $50K | 1 |
| Q1 2025 | $50K | 1 |
| Q2 2025 | $50K | 1 |
| Q3 2025 | $170K | 2 |
| Q4 2025 | $170K | 2 |
| Q1 2026 | $170K | 2 |
| Q2 2026 | $170K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$510K · 14 reports
- Science and technology$240K · 4 reports
- Medicare and Medicaid$200K · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES10 reports
- SENATE10 reports
- Health & Human Services, Dept of (HHS)8 reports
- Centers For Medicare and Medicaid Services (CMS)4 reports
- Food & Drug Administration (FDA)3 reports
- Office of Management & Budget (OMB)3 reports
Firms it paid
| Firm | ||
|---|---|---|
| Continental Strategy | $480K | 4 quarters |
| The McManus Group | $470K | 10 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| LUKE NICKLESS | Former Senior Policy Advisor, Appropriations, House Committee on the Budget | Q2 2026 |
| TIMOTHY COSTA | Former Chief of Staff to Dan Meuser | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | The McManus Group | $50K |
| 07/19for Q2 | Continental Strategy | $120K |
| 04/20for Q1 | The McManus Group | $50K |
| 04/18for Q1 | Continental Strategy | $120K |
| 01/20for Q4 2025 | The McManus Group | $50K |
| 01/19for Q4 2025 | Continental Strategy | $120K |
| 25/10/20for Q3 2025 | The McManus Group | $50K |
| 25/10/20for Q3 2025 | Continental Strategy | $120K |
| 25/08/06for Q3 2025 | Continental Strategy | Under $5,000 |
| 25/07/21for Q2 2025 | The McManus Group | $50K |
| 25/04/21for Q1 2025 | The McManus Group | $50K |
| 25/01/21for Q4 2024 | The McManus Group | $50K |
| 24/10/21for Q3 2024 | The McManus Group | $50K |
| 24/07/16for Q2 2024 | The McManus Group | $50K |
| 24/04/22for Q1 2024 | The McManus Group | $20K |
| 24/03/27for Q1 2024 | The McManus Group | Under $5,000 |